Integrating Pharmacokinetics Knowledge into a Drug Ontology As an Extension to Support Pharmacogenomics

The newly developed U.S. Common Medication Information Infrastructure was used as a basis to capture and formally express the properties of drugs relevant to research and the clinical application of pharmacogenomics. Two associated taxonomies within the model, Mechanism of Action and Physiologic Effect, were enriched to accommodate pharmacogenomic use-cases; the 4,000 active ingredients in the VA NDF-RT drug file were related to the enhanced taxonomies. Pharmacokinetics were independently modeled for pharmacogenomics and tested against thirty-one high-profile drugs to demonstrate our approach.

[1]  Steven H. Brown,et al.  A semantic normal form for clinical drugs in the UMLS: early experiences with the VANDF , 2002, AMIA.

[2]  Judith V. Douglas,et al.  Computerized Large Integrated Health Networks: The VA Sucess , 1997 .

[3]  Richard M Weinshilboum,et al.  Pharmacogenomics and reducing the frequency of adverse drug events. , 2003, Pharmacogenomics.

[4]  R. Weinshilboum.  Inheritance and drug response. , 2003, The New England journal of medicine.

[5]  Russ B Altman,et al.  Indexing pharmacogenetic knowledge on the World Wide Web. , 2003, Pharmacogenetics.

[6]  C G Chute,et al.  Drugs, codes, standards, and other incompatible things in the dark. , 2001, M.D. computing : computers in medical practice.

[7]  M A Musen,et al.  Domain Ontologies in Software Engineering: Use of Protégé with the EON Architecture , 1998, Methods of Information in Medicine.

[8]  Kent A. Spackman,et al.  Role grouping as an extension to the description logic of Ontylog, motivated by concept modeling in SNOMED , 2002, AMIA.

[9]  Russ B. Altman,et al.  PharmGKB: the Pharmacogenetics Knowledge Base , 2002, Nucleic Acids Res..

[10]  E. Oren,et al.  Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. , 2001, JAMA.

[11]  Russ B. Altman,et al.  Ontology Development for a Pharmacogenetics Knowledge Base , 2001, Pacific Symposium on Biocomputing.

[12]  R. Weinshilboum,et al.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. , 1980, American journal of human genetics.

[13]  Peter L. Elkin,et al.  Initializing the VA medication reference terminology using UMLS metathesaurus co-occurrences , 2002, AMIA.